Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
451
Fiserv Inc
FISV
$28B
| $6.84M | 0.03% |
101,832
-29,917
| -23% | -$2.5M |
|
452
O'Reilly Automotive
ORLY
$72.1B
| $6.8M | 0.03% |
74,605
+35,111
| +89% | +$3.43M |
|
453
Hercules Capital
HTGC
$3.21B
| $6.78M | 0.03% |
360,446
+143,117
| +66% | +$2.58M |
|
|
CTLP
454
DELISTED
Cantaloupe
CTLP
| $6.68M | 0.03% |
628,841
-35,028
| -5% | -$371K |
|
|
CAI
455
Caris Life Sciences
CAI
$7.42B
| $6.68M | 0.03% |
+247,407
| New | +$6.97M |
|
|
FLG
456
Flagstar Bank National Association
FLG
$5.59B
| $6.67M | 0.03% |
529,662
+196,551
| +59% | +$2.35M |
|
457
PG&E
PCG
$38.8B
| $6.61M | 0.03% |
411,082
-31,547
| -7% | -$504K |
|
458
CALL
Meta Platforms (Facebook)
META
$1.4T
| $6.6M | 0.03% |
+10,000
| New | +$6.68M |
|
459
ON Semiconductor
ON
$28.9B
| $6.59M | 0.03% |
121,741
+117,333
| +2,662% | +$6.02M |
|
460
Brinker International
EAT
$10.6B
| $6.59M | 0.03% |
45,896
+15,915
| +53% | +$2.08M |
|
461
Avery Dennison
AVY
$13.9B
| $6.57M | 0.03% |
36,103
+30,195
| +511% | +$5.22M |
|
462
Viridian Therapeutics
VRDN
$2.75B
| $6.56M | 0.03% |
217,434
+159,506
| +275% | +$4.37M |
|
|
463
Union Pacific
UNP
$183B
| $6.54M | 0.03% |
28,274
-438,605
| -94% | -$100M |
|
464
Ryan Specialty Holdings
RYAN
$11.1B
| $6.52M | 0.03% |
+126,266
| New | +$6.93M |
|
|
ACLX
465
DELISTED
Arcellx
ACLX
| $6.46M | 0.03% |
99,131
-401,184
| -80% | -$32M |
|
466
Monster Beverage
MNST
$93.6B
| $6.46M | 0.03% |
168,556
-115,186
| -41% | -$4.13M |
|
|
AL
467
CALL
DELISTED
Air Lease Corp
AL
| $6.42M | 0.03% |
100,000
+80,000
| +400% | +$5.11M |
|
468
UFP Technologies
UFPT
$2.39B
| $6.37M | 0.03% |
+28,694
| New | +$6.15M |
|
|
FRMI
469
Fermi Inc
FRMI
$3.79B
| $6.37M | 0.03% |
+795,978
| New | +$15.5M |
|
470
PennyMac Financial
PFSI
$3.9B
| $6.37M | 0.03% |
48,291
+37,179
| +335% | +$4.74M |
|
471
nCino
NCNO
$2.26B
| $6.36M | 0.03% |
248,240
+110,977
| +81% | +$2.82M |
|
|
AMBQ
472
Ambiq Micro
AMBQ
$1.43B
| $6.32M | 0.03% |
221,810
-52,277
| -19% | -$1.5M |
|
473
Diageo
DEO
$52.6B
| $6.32M | 0.03% |
73,212
+26,751
| +58% | +$2.46M |
|
474
American International
AIG
$39.8B
| $6.31M | 0.03% |
73,810
+61,912
| +520% | +$4.95M |
|
475
UGI
UGI
$8.06B
| $6.29M | 0.03% |
168,071
-33,637
| -17% | -$1.19M |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.